A randomized, open label, two periods, two sequences, single dose, bioequivalence study of Zadiva® 240mg capsule of Nano Alvand Pharm Co., IRAN in comparison of Tecfidera 240mg capsule of Biogen, in 24 healthy adult subjects under fasting conditions

A randomized, open label, two treatments, two periods, two sequences, single dose, crossover, bioequivalence study of Sitagliptin 2*50mg tablet of Arya Pharm Co., IRAN and Januvia®100mg tablet of MSD UK, in 24 healthy adult subjects under fasting conditions

A randomized, open label, two periods, two sequence, single dose, bioequivalence study of Vana Flecainide 100mg tablet of Vana Darou Gostar Pharm Co., IRAN in comparison of Flecainide 100mg tablet of Sandoz®, in 24 healthy adult subjects under fasting conditions

A randomized, open label, two periods, two sequences, single dose, bioequivalence study of Gabapentin 300mg capsule of Alborz Darou Pharm Co., IRAN in comparison of Neurontin 300mg capsule of Pfizer, in 24 healthy adult subjects under fasting conditions

A randomized, open label, two sequence, single dose, bioequivalence study of Febuxostat 80mg tablet of Kimia Ara Heram Pharm Co., IRAN in comparison of Adenuric 80mg tablet of Menarini, in 24 healthy adult subjects under fasting conditions

A randomized, open label, two sequences, single dose, bioequivalence study of Rosuvastatin 40mg tablet of Cosar Pharm Co., IRAN in comparison of Crestor® 40mg tablet of Astra-Zeneca, in 24 healthy adult subjects under fasting conditions

A randomized, open label, two sequences, single dose, bioequivalence study of Arystatin® 40mg tablet of Arya Pharm Co., IRAN in comparison of Crestor® 40mg tablet of Astra-Zeneca, in 24 healthy adult subjects under fasting conditions

A randomized, open label, two period, two sequence, single dose, bioequivalence study of Eplerenone 50mg tablet of Alborz Darou Pharm Co., IRAN in comparison of Inspra 50mg tablet of Pfizer, in 24 healthy adult subjects under fasting conditions

A randomized, open label, two treatment, two period, two sequence, single dose, bioequivalence study of Montelukast 10mg tablet of Amin Pharm Co., IRAN and Singulair 10mg tablet of MSD, in 24 healthy adult subjects under fasting conditions